Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dao-bin Zhou

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2006
[An iron regulator hepcidin is affected by EPO]Xue-Feng Sun, Dao-Bin Zhou, Yong-Qiang Zhao
Oncology Letters|September 12, 2012
Rituximab purging and maintenance therapy combined with autologous stem cell transplantation in patients with diffuse large B-cell lymphomaWei Zhang, Li Jiao, Dao-Bin Zhou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 11, 2019
[Clinical Significance of Detecting the Erythrocyte Life Expectancy in Patients with Malignant Lymphoma Complicated with Anemia]Qiang Pei, Hao-Rui Shen, Wei Zhang, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|January 5, 2016
[Aeromonas Sobria Infection in Patients with Acute Leukemia:Clinical Features and Outcome]Lu Zhang, Jian Li, Dao-bin Zhou, et al.
Leukemia & Lymphoma|May 18, 2025
Evidence of the modified staging system and comparative performance of IPSS and revised IPSS in a Single-Center Asian cohort with Waldenström macroglobulinemiaJia Chen, Jian Li, Dao-Bin Zhou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 6, 2018
[Clinical Analysis of 10 Cases of AIDS Complicated with Lymphoma]Qiang Pei, Xiao Han, Yan Zhang, et al.
Journal of Oncology|November 28, 2022
Clinical Characteristics, Outcomes, and Risk Factors for Patients with Diffuse Large B-Cell Lymphoma and Development of Nomogram to Identify High-Risk PatientsJinrong Zhao, Yan Zhang, Wei Wang, et al.
Hematology (Amsterdam, Netherlands)|June 29, 2021
Risk of hepatitis B virus reactivation following ruxolitinib treatment in patients with myeloproliferative neoplasmsMing-Hui Duan, Xin-Xin Cao, Long Chang, et al.
Annals of Hematology|August 24, 2017
Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester diseaseXin-Xin Cao, Na Niu, Jian Sun, et al.
Zhonghua Yi Xue Za Zhi|July 2, 2009
[Efficacy of rituximab therapy on diffuse large B-cell lymphoma with different Fcgamma RIIIA gene polymorphisms: a prospective study]Wei Zhang, Xuan Wang, Ming-Hui Duan, et al.
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2006
[An iron regulator hepcidin is affected by EPO]Xue-Feng Sun, Dao-Bin Zhou, Yong-Qiang Zhao
Oncology Letters|September 12, 2012
Rituximab purging and maintenance therapy combined with autologous stem cell transplantation in patients with diffuse large B-cell lymphomaWei Zhang, Li Jiao, Dao-Bin Zhou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 11, 2019
[Clinical Significance of Detecting the Erythrocyte Life Expectancy in Patients with Malignant Lymphoma Complicated with Anemia]Qiang Pei, Hao-Rui Shen, Wei Zhang, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|January 5, 2016
[Aeromonas Sobria Infection in Patients with Acute Leukemia:Clinical Features and Outcome]Lu Zhang, Jian Li, Dao-bin Zhou, et al.
Leukemia & Lymphoma|May 18, 2025
Evidence of the modified staging system and comparative performance of IPSS and revised IPSS in a Single-Center Asian cohort with Waldenström macroglobulinemiaJia Chen, Jian Li, Dao-Bin Zhou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 6, 2018
[Clinical Analysis of 10 Cases of AIDS Complicated with Lymphoma]Qiang Pei, Xiao Han, Yan Zhang, et al.
Journal of Oncology|November 28, 2022
Clinical Characteristics, Outcomes, and Risk Factors for Patients with Diffuse Large B-Cell Lymphoma and Development of Nomogram to Identify High-Risk PatientsJinrong Zhao, Yan Zhang, Wei Wang, et al.
Hematology (Amsterdam, Netherlands)|June 29, 2021
Risk of hepatitis B virus reactivation following ruxolitinib treatment in patients with myeloproliferative neoplasmsMing-Hui Duan, Xin-Xin Cao, Long Chang, et al.
Annals of Hematology|August 24, 2017
Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester diseaseXin-Xin Cao, Na Niu, Jian Sun, et al.
Zhonghua Yi Xue Za Zhi|July 2, 2009
[Efficacy of rituximab therapy on diffuse large B-cell lymphoma with different Fcgamma RIIIA gene polymorphisms: a prospective study]Wei Zhang, Xuan Wang, Ming-Hui Duan, et al.
Pageof 18